Author:
Xu Wei,Li Yan,Wang Xueli,Chen Bo,Liu Shan,Wang Yan,Zhao Weihong,Wu Jianqing
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference50 articles.
1. Henson ES, Gibson SB. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal. 2006;18:2089–97.
2. Salomon DS, Brandt R, Ciardiello F, Normanno NE. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol. 1995;19:183–232.
3. Fenton SE, Groce NS, Lee DC. Characterization of the mouse epidermal growth factor promoter and 5′-flanking region. Role for an atypical TATA sequence. J Biol Chem. 1996;271:30870–8.
4. Price PM, Megyesi J, Saggi S, Safirstein RL. Regulation of transcription by the rat EGF gene promoter in normal and ischemic murine kidney cells. Am J Physiol. 1995;268:F664–70.
5. Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, et al. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA. 2008;299:53–60.